Nitrates In Combination With Hydralazine in cardiorEnal Syndrome (NICHE) Study

A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 100 participants.

Also called NCT02343393

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 100 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT02343393
Start date
(registry gives no type) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Singapore (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT02343393. Randomized; single masking; primary purpose treatment. Start 2015-01 (registry gives no type); primary completion 2015-12 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Nitrates In Combination With Hydralazine in cardiorEnal Syndrome (NICHE) Study
Acronym
NICHE
Condition
Cardio-Renal Syndrome
Intervention (Drug)
Hydralazine
Intervention (Drug)
Isosorbide Dinitrate
Lead sponsor
National University Hospital, Singapore (class: other)
Collaborator
Singapore Clinical Research Institute (class: other)
Collaborator
Changi General Hospital (class: other)
Collaborator
National Heart Centre Singapore (class: other)

Record details

Record id
cardio:ct-nct02343393
Content hash
3ced53758e14fc3c6666ff453c024f032d0f46d249886581513d673ccfa77630